GSK plc
GSK is a United Kingdom-based biopharmaceutical company that researches, develops, manufactures and commercializes specialty medicines and vaccines. Its therapeutic focus includes infectious diseases, immunology and oncology, using vaccine science and a range of medicinal approaches. The official investor website confirms London-listed ordinary shares and New York-listed American depositary shares under the GSK symbol; these are representations of one listed company. Its development work integrates vaccines, specialty medicines and research into immune-mediated diseases.
Company at a glance
Corporate information
- Company entity
- GSK plc
- Headquarters / principal office
- United Kingdom
- Founded
- Not verified
- Ownership / capital status
- Publicly tradedPublicly listed
- Official corporate reference
- https://gsk.com
- LinkedIn company page
- Independent company page not verified
Profile review: 2026-11-08 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Listed issuer and R&D focus
LSE: GSK NYSE: GSK
vaccines · small-molecule · biologics
infectious-diseases · immunology · oncology
Last independently verified:
Disease tags match recorded text mentions and require program-level verification.
Technology, programs & evidence
GSK is a United Kingdom-based biopharmaceutical company that researches, develops, manufactures and commercializes specialty medicines and vaccines. Its therapeutic focus includes infectious diseases, immunology and oncology, using vaccine science and a range of medicinal approaches. The official investor website confirms London-listed ordinary shares and New York-listed American depositary shares under the GSK symbol; these are representations of one listed company. Its development work integrates vaccines, specialty medicines and research into immune-mediated diseases.
Business, technology & evidence
- SecuritiesLSE: GSK / NYSE: GSK
Individual program detail is not recorded. Consult the original sources below.
Related news & literature
Company-name matches are discovery leads; verify entity identity and transaction roles in the original source.
Showing 0 / 0 related items
No cataloged update explicitly mentions this company.
Same-field reading (not company-specific)
Research this company together
Discussions are for signed-in members. Personal notes remain separate from company research.
Sign in to joinSources & open questions
- Official issuer and R&D disclosure · GSK plc ↗GSK plc ·
- Official issuer and R&D disclosure · GSK plc ↗GSK plc ·
Inclusion is not endorsement or partner qualification. Assess company claims, clinical evidence, and project-specific capabilities separately.